<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6775">Mesalamine</z:chebi> suppositories have been used widely for the treatment of distal <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and considered to be safer than systemic administration for its limited systemic absorption </plain></SENT>
<SENT sid="1" pm="."><plain>However, previous studies have shown that <z:chebi fb="0" ids="6775">mesalamine</z:chebi> suppository occasionally causes severe hypersensitivity reactions including <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e>, <z:hpo ids='HP_0002583'>colitis</z:hpo> exacerbation and <z:hpo ids='HP_0011009'>acute</z:hpo> eosinophilic <z:hpo ids='HP_0002090'>pneumonia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we present a 25-year-old woman with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> with <z:hpo ids='HP_0002573'>bloody diarrhea</z:hpo> accompanied by <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> and <z:hpo ids='HP_0001945'>fever</z:hpo> which were aggravated after introduction of <z:chebi fb="0" ids="6775">mesalamine</z:chebi> suppositories </plain></SENT>
<SENT sid="3" pm="."><plain>In light of symptom exacerbation of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, increased inflammatory injury of colon mucosa shown by colonoscopy and elevated peripheral eosinophil count after <z:chebi fb="0" ids="6775">mesalamine</z:chebi> suppositories administration, and the Naranjo algorithm score of 10, the possibility of hypersensitivity reaction to <z:chebi fb="0" ids="6775">mesalamine</z:chebi> suppositories should be considered, warning us to be aware of this potential reaction after administration of <z:chebi fb="0" ids="6775">mesalamine</z:chebi> formulations even if it is the suppositories </plain></SENT>
</text></document>